DE SB143

Redefines the practice of optometry to include examination, measurement, diagnosis, treatment and prevention of eye conditions using subjective or objective means including automated testing devices.

Establishes pharmaceutical prescribing authority for optometrists based on graduate-level coursework in general and ocular pharmacology, including limited controlled substance prescriptions (Schedule II Hydrocodone and Schedules III-V limited to 72-hour supply) and oral steroids limited to single dose packs.

Prohibits optometrists from performing ophthalmic laser surgery on the globe, removing pterygia and Salzmann's nodules, performing incisional corneal refractive surgery, and procedures requiring injectable/general anesthesia, moderate sedation, or globe penetration.

Creates a "Diagnostic" license category for optometrists who cannot utilize therapeutic pharmaceutical agents or perform procedures requiring subsequent therapeutic treatment, with restrictions on supervision of internships and prohibition on license reactivation if lapsed.

Requires optometrists seeking controlled substance provider numbers to register with the Drug Enforcement Agency and biennially with the Office of Controlled Substances, and submit proof of graduate-level coursework in general and ocular pharmacology.